Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.

In a real-world cohort of patients treated within 8 weeks of diagnosis, and with the limitations of a retrospective study, later TTI did not have a negative impact on survival outcomes in mCRC and mPC.